Context Capital Management’s ProKidney PROK Stock Holding History

Context Capital Management’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-149,400	Closed	-$1.48M	–	628
2022 Q1	$1.48M	Buy	149,400 +50,000	+50%	+$493K	0.1%	273
2021 Q4	$984K	Sell	99,400 -600	-0.6%	-$5.93K	0.08%	300
2021 Q3	$980K	Hold	100,000	–	–	0.1%	232
2021 Q2	$1.01M	Buy	+100,000	New	+$1.01M	0.09%	223

Other funds holding PROK

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ACA

Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

Context Capital Management's PROK Position: Q2 2022 in Review

Context Capital Management sold out of ProKidney (PROK) in Q2 2022, closing a stake of 149,400 shares — an estimated $1.48M sold.

Context Capital Management first reported a position in PROK in Q2 2021 and held it in 4 quarters. The position peaked at $1.48M in Q1 2022. 67 funds tracked by Wall St. Rank hold PROK as of Q2 2022.

Context Capital Management reported no remaining ProKidney position as of Q2 2022 after selling out during the quarter.
Context Capital Management sold 149,400 ProKidney shares in Q2 2022, an estimated $1.48M.
Context Capital Management first reported a position in ProKidney in Q2 2021 and held it in 4 quarters.
Context Capital Management's ProKidney position peaked at $1.48M in Q1 2022.
67 funds tracked by Wall St. Rank held ProKidney as of Q2 2022.

Based on Context Capital Management's 13F filing for Q2 2022, filed 3 Aug 2022.